Potent and selective bradykinin B1
receptor antagonist (pA2
= 8.49). Displays no activity at B2
receptors. Reduces mechanical hypernociception in a mouse model of neuropathic pain. Metabolically stable.
The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
All Tocris products are intended for laboratory research use only.
Neuropathic pain-like behavior after brachial plexus avulsion in mice: the relevance of kinin B1 and B2 receptors.
Quintao et al.
Retinal plasma extravasation in streptozotocin-diabetic rats mediated by kinin B1 and B2 receptors.
Abdouh et al.
Structure-activity studies of B1 receptor-related peptides.
Gobeil et al.
The citations listed below are publications that use Tocris products. Selected citations for R 715 include:
Showing Results 1 - 4 of 4